Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1901
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.83M | ﹤0.01% |
217,132
+7,681
| +4% | +$124K |
|
1902
Nu Holdings
NU
$69.9B
| $2.83M | ﹤0.01% |
595,196
+236,571
| +66% | +$1.05M |
|
1903
Voya Financial
VOYA
$9.07B
| $2.82M | ﹤0.01% |
39,497
-157,163
| -80% | -$11M |
|
1904
Hims & Hers Health
HIMS
$7.15B
| $2.82M | ﹤0.01% |
283,926
+251,338
| +771% | +$2.2M |
|
1905
Aaon
AAON
$7.62B
| $2.79M | ﹤0.01% |
43,248
+12,019
| +38% | +$661K |
|
1906
CALL
C3.ai
AI
$1.52B
| $2.79M | ﹤0.01% |
+83,000
| New | +$1.7M |
|
|
WWE
1907
DELISTED
World Wrestling Entertainment
WWE
| $2.78M | ﹤0.01% |
30,494
+24,021
| +371% | +$2.05M |
|
1908
CALL
Omnicell
OMCL
$1.71B
| $2.78M | ﹤0.01% |
+47,400
| New | +$2.61M |
|
1909
Kura Oncology
KURA
$807M
| $2.78M | ﹤0.01% |
227,115
+41,066
| +22% | +$512K |
|
1910
Urban One Class D
UONEK
$23.5M
| $2.77M | ﹤0.01% |
50,360
+3,288
| +7% | +$163K |
|
1911
PUT
Canadian Natural Resources
CNQ
$96.7B
| $2.77M | ﹤0.01% |
100,000
+84,800
| +558% | +$2.4M |
|
1912
iShares Gold Trust
IAU
$63B
| $2.76M | ﹤0.01% |
73,983
+58,768
| +386% | +$2.11M |
|
1913
Rocket Pharmaceuticals
RCKT
$378M
| $2.76M | ﹤0.01% |
161,142
-19,083
| -11% | -$374K |
|
1914
CALL
GitLab
GTLB
$6.06B
| $2.74M | ﹤0.01% |
+80,000
| New | +$3.51M |
|
1915
Papa John's
PZZA
$1.01B
| $2.74M | ﹤0.01% |
36,610
+17,283
| +89% | +$1.46M |
|
|
CWEN.A
1916
DELISTED
Clearway Energy Class A
CWEN.A
| $2.74M | ﹤0.01% |
91,292
+12,679
| +16% | +$386K |
|
1917
Valmont Industries
VMI
$9.42B
| $2.73M | ﹤0.01% |
8,564
+2,144
| +33% | +$684K |
|
1918
Twist Bioscience
TWST
$6.2B
| $2.73M | ﹤0.01% |
180,967
-2,550
| -1% | -$56.3K |
|
1919
HUB Group
HUBG
$2.8B
| $2.72M | ﹤0.01% |
64,914
-3,974
| -6% | -$173K |
|
1920
Brink's
BCO
$4.8B
| $2.72M | ﹤0.01% |
40,780
+10,455
| +34% | +$663K |
|
|
PRMW
1921
DELISTED
Primo Water Corporation
PRMW
| $2.72M | ﹤0.01% |
177,217
+31,168
| +21% | +$477K |
|
1922
CNA Financial
CNA
$14.6B
| $2.72M | ﹤0.01% |
69,615
-6,529
| -9% | -$274K |
|
1923
CoreCivic
CXW
$3B
| $2.72M | ﹤0.01% |
295,237
-87,763
| -23% | -$901K |
|
1924
Toast
TOST
$19.1B
| $2.71M | ﹤0.01% |
152,878
-31,256
| -17% | -$616K |
|
|
MTVC
1925
DELISTED
Motive Capital Corp II
MTVC
| $2.71M | ﹤0.01% |
259,245
| – | – |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.